OncoMed Pharmaceuticals, Inc.  
     
 
 
 

Our Mission

OncoMed Pharmaceuticals is a clinical-stage biotechnology company dedicated to improving cancer treatment by creating novel medicines that address the fundamental biologic pathways critical to tumor initiation, growth, metastases and recurrence. We are leveraging our understanding of cancer stem cell pathways and immuno-oncology targets to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer.

R&D Day

April 29, 2015 in NYC OncoMed 2015 Research & Development Day
  Press Release Archives 
 

Latest Presentations

June 2015 2015 American Society of Clinical Oncology (ASCO) Annual Meeting April 2015 European Lung Cancer Conference